Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

798

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2022

Study Completion Date

December 31, 2023

Conditions
Type 2 DiabetesCoronary Artery DiseaseHypertensionDyslipidemia
Interventions
OTHER

intensive control

use any medication to achieve systolic blood pressure less than 120mmHg and LDL cholesterol within 70-85mg/dl

OTHER

standard control

use any medication to achieve systolic blood pressure less than 130mmHg and LDL cholesterol less than 100mg/dl

Trial Locations (2)

903-0215

University Hospital, University of the Ryukyus, Nishihara

849-8501

Saga University Hospital, Saga

All Listed Sponsors
collaborator

University of the Ryukyus

OTHER

lead

Takeshi Morimoto

OTHER

NCT01422421 - Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease | Biotech Hunter | Biotech Hunter